Canada has a longstanding commitment to global health through its support of the Global Fund to Fight AIDS, Tuberculosis, and Malaria, which it has backed since the organization’s inception in 2002. The programs supported by the Global Fund have saved an estimated 70 million lives and reduced combined death rates from these diseases by nearly two-thirds in the countries where it operates. These efforts also strengthen both global and Canadian health security, addressing the needs of the poorest and most marginalized populations.
On November 21, 2025, in Johannesburg, South Africa, Cindy Termorshuizen, Deputy Minister for the G7 Summit, announced Canada’s pledge to the Global Fund’s eighth replenishment, committing $1.02 billion over three years (2026–2028). This investment aims to protect millions of people, reduce new infections, and further lower mortality rates from HIV, tuberculosis, and malaria, which remain among the world’s deadliest infectious diseases.
In 2024 alone, the Global Fund supported 25.6 million people with HIV medicines, treated 7.4 million for tuberculosis, and provided 162 million insecticide-treated mosquito nets to prevent malaria. Additionally, it invested $2.7 billion to strengthen health systems in low- and middle-income countries, enhancing laboratories, supply chains, and disease tracking. These efforts improve the ability of countries to respond to these three epidemics and prepare for future health threats.
Canada’s pledge demonstrates its continued leadership in global health and aligns with domestic priorities by recalibrating contributions to pre-pandemic levels. Through partnerships with organizations like the Global Fund, Canada invests in solutions that deliver significant returns by fostering healthier communities, strengthening economic security, and promoting global stability.
The Global Fund represents Canada’s largest annual investment in global health, with the country having contributed over $5.3 billion since 2002. It mobilizes resources from governments, the private sector, and foundations to meet urgent health needs, reinforce health systems, and strengthen global health security. The Fund plays a critical role in financing programs for HIV, tuberculosis, and malaria, providing significant shares of international funding: 26% for HIV, 73% for TB, and 59% for malaria. Canada also supports TB innovations through Stop TB’s TB REACH initiative, working closely with the Global Fund to expand access to lifesaving treatments for vulnerable populations.
